Type 2 diabetes drug cost-effective for cardiovascular and kidney benefits, finds Australian study

Medication that helps reduce a person’s risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia’s entire population of people with type 2 diabetes, a new study has found.

Type 2 diabetes drug cost-effective for cardiovascular and kidney benefits, finds Australian study

Clinician nudge ups initiation of statin prescribing in primary care

Early life experiences can affect gene activity more than half a lifetime later

The poorest UK children have worse health and educational outcomes in adolescence, new study finds

Risk of cervical cancer found to be twice as high in women with mental illness

State-by-state analysis of COVID impact reveals driving forces behind variations in health, education, and economy

Health experts call for bold action to prioritize health over profit

Comments

Leave a reply Cancel reply

More in Innovations

Analysis suggests surgery is safe for patients two weeks after positive COVID diagnosis, as long as they have recovered

Big data and AI meet cancer research

Rates of autism climb to new highs in the US, with California setting record numbers

Points to consider when using interferon assays

Important

Study may elucidate metformin’s potential role in longevity through DNA methylation

Researchers reveal genetic predisposition to immunity against new variants of COVID-19

The tragedy of sudden infant death syndrome: A pediatrician explains how to protect your baby

Must Read

Mass spectrometry-based identification of COVID-19 biomarkers

Bioorthogonal system for targeted release of nitrite ions into cancer cells

Staph infection-induced kidney disease may be linked to bacterial gene mutation

Popular Posts

Pornhub traffic doubled in D.C. on Election Day

12 sex tips for disabled people and their partners

User Experience Signals: The Essential SEO Factors

Lunar eclipse November 8: How to watch the last ‘blood moon’ of 2022